PuSH - Publication Server of Helmholtz Zentrum München

Journal browsing

57 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
Blandino, A.* et al.: Identification of circulating lncRNAs associated with gallbladder cancer risk by tissue-based preselection, cis-eQTL validation, and analysis of association with genotype-based expression. Cancers 14:634 (2022)
Erlmeier, F.* et al.: MALDI mass spectrometry imaging—prognostic pathways and metabolites for renal cell carcinomas. Cancers 14:1763 (2022)
Geppert, J. et al.: Aging aggravates cachexia in tumor-bearing mice. Cancers 14:90 (2022)
Kraus, K.M. et al.: Treatment planning study for microbeam radiotherapy using clinical patient data. Cancers 14:685 (2022)
Lopez-Millan, B.* et al.: The multi-kinase inhibitor EC-70124 is a promising candidate for the treatment of FLT3-ITD-positive acute myeloid leukemia. Cancers 14:1593 (2022)
Zhao, X.* et al.: Validation of novel molecular imaging targets identified by functional genomic mRNA profiling to detect dysplasia in Barrett's Esophagus. Cancers 14:2462 (2022)
Aftahy, A.K.* et al.: Surgical management of jugular foramen schwannomas. Cancers 13:4218 (2021)
Baumeister, P. ; Zhou, J.* ; Canis, M.* & Gires, O.: Epithelial-to-mesenchymal transition-derived heterogeneity in head and neck squamous cell carcinomas. Cancers 13:5355 (2021)
Borm, K.J.* et al.: Excluding lung tissue from the ptv during internal mammary irradiation. A safe technique for oar-sparing? Cancers 13:1951 (2021)
Borm, K.J.* et al.: A comprehensive prospective comparison of acute skin toxicity after hypofractionated and normofractionated radiation therapy in breast cancer. Cancers 13:5826 (2021)
Brunn, D.* et al.: Interferon regulatory factor 9 promotes lung cancer progression via regulation of versican. Cancers 13:208 (2021)
Dobiasch, S. et al.: Histopathological tumor and normal tissue responses after 3d-planned arc radiotherapy in an orthotopic xenograft mouse model of human pancreatic cancer. Cancers 13:5656 (2021)
Freuer, D.* et al.: Body fat distribution and risk of breast, endometrial, and ovarian cancer: A two-sample mendelian randomization study. Cancers 13:5053 (2021)
Gottschlich, A.* ; Endres, S. & Kobold, S.: Therapeutic strategies for targeting IL-1 in cancer. Cancers 13:477 (2021)
Gulde, S. et al.: Gender-specific efficacy revealed by head-to-head comparison of pasireotide and octreotide in a representative in vivo model of nonfunctioning pituitary tumors. Cancers 13:3097 (2021)
Gutschenritter, T.* et al.: The judicious use of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy in the management of large brain metastases. Cancers 13:70 (2021)
Jansen, L.* et al.: Estimation of the potentially avoidable excess deaths associated with socioeconomic inequalities in cancer survival in Germany. Cancers 13:357 (2021)
Klymenko, O.* et al.: Radiooncological view on therapy outcome after multidisciplinary treatment of sinonasal tumors. Cancers 13:2364 (2021)
Kraus, K.M. et al.: Potential morbidity reduction for lung stereotactic body radiation therapy using respiratory gating. Cancers 13:5092 (2021)
Lang, D.M. ; Peeken, J.C. ; Combs, S.E. ; Wilkens, J.J.* & Bartzsch, S.: Deep learning based HPV status prediction for oropharyngeal cancer patients. Cancers 13:786 (2021)